Notifications can be managed in browser preferences.
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests.
The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion.
